LUCD logo

Lucid Diagnostics (LUCD) EBITDA

Annual EBITDA

-$49.75 M
+$4.48 M+8.25%

December 31, 2023


Summary


Performance

LUCD EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLUCDprofitabilitymetrics:

Quarterly EBITDA

-$12.15 M
-$1.39 M-12.86%

September 30, 2024


Summary


Performance

LUCD Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLUCDprofitabilitymetrics:

TTM EBITDA

-$43.21 M
+$1.28 M+2.87%

September 30, 2024


Summary


Performance

LUCD TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLUCDprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

LUCD EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+8.3%+9.5%+19.8%
3 y3 years-500.9%+9.5%+19.8%
5 y5 years-1025.5%+9.5%+19.8%

LUCD EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-81.5%+8.3%-20.4%+22.1%-57.6%+24.9%
5 y5-year-1025.5%+8.3%-501.2%+22.1%-2037.5%+24.9%
alltimeall time-1025.5%+8.3%-501.2%+22.1%-2037.5%+24.9%

Lucid Diagnostics EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$12.15 M(+12.9%)
-$43.21 M(-2.9%)
Jun 2024
-
-$10.77 M(+6.6%)
-$44.49 M(+0.6%)
Mar 2024
-
-$10.10 M(-0.9%)
-$44.25 M(-11.1%)
Dec 2023
-$49.75 M(-8.3%)
-$10.19 M(-24.1%)
-$49.75 M(-7.6%)
Sep 2023
-
-$13.43 M(+27.6%)
-$53.87 M(-0.6%)
Jun 2023
-
-$10.53 M(-32.5%)
-$54.19 M(-5.9%)
Mar 2023
-
-$15.60 M(+9.1%)
-$57.58 M(+6.2%)
Dec 2022
-$54.23 M
-$14.30 M(+4.0%)
-$54.23 M(+6.0%)
Sep 2022
-
-$13.76 M(-1.2%)
-$51.16 M(+16.5%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$13.92 M(+13.7%)
-$43.92 M(+21.9%)
Mar 2022
-
-$12.25 M(+9.0%)
-$36.01 M(+31.4%)
Dec 2021
-$27.41 M(+231.1%)
-$11.24 M(+72.7%)
-$27.42 M(+45.0%)
Sep 2021
-
-$6.51 M(+8.2%)
-$18.91 M(+31.1%)
Jun 2021
-
-$6.02 M(+64.8%)
-$14.42 M(+71.6%)
Mar 2021
-
-$3.65 M(+33.6%)
-$8.40 M(+76.8%)
Dec 2020
-$8.28 M(+87.3%)
-$2.73 M(+35.1%)
-$4.75 M(+135.1%)
Sep 2020
-
-$2.02 M
-$2.02 M
Dec 2019
-$4.42 M
-
-

FAQ

  • What is Lucid Diagnostics annual EBITDA?
  • What is the all time high annual EBITDA for Lucid Diagnostics?
  • What is Lucid Diagnostics annual EBITDA year-on-year change?
  • What is Lucid Diagnostics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Lucid Diagnostics?
  • What is Lucid Diagnostics quarterly EBITDA year-on-year change?
  • What is Lucid Diagnostics TTM EBITDA?
  • What is the all time high TTM EBITDA for Lucid Diagnostics?
  • What is Lucid Diagnostics TTM EBITDA year-on-year change?

What is Lucid Diagnostics annual EBITDA?

The current annual EBITDA of LUCD is -$49.75 M

What is the all time high annual EBITDA for Lucid Diagnostics?

Lucid Diagnostics all-time high annual EBITDA is -$4.42 M

What is Lucid Diagnostics annual EBITDA year-on-year change?

Over the past year, LUCD annual EBITDA has changed by +$4.48 M (+8.25%)

What is Lucid Diagnostics quarterly EBITDA?

The current quarterly EBITDA of LUCD is -$12.15 M

What is the all time high quarterly EBITDA for Lucid Diagnostics?

Lucid Diagnostics all-time high quarterly EBITDA is -$2.02 M

What is Lucid Diagnostics quarterly EBITDA year-on-year change?

Over the past year, LUCD quarterly EBITDA has changed by +$1.28 M (+9.52%)

What is Lucid Diagnostics TTM EBITDA?

The current TTM EBITDA of LUCD is -$43.21 M

What is the all time high TTM EBITDA for Lucid Diagnostics?

Lucid Diagnostics all-time high TTM EBITDA is -$2.02 M

What is Lucid Diagnostics TTM EBITDA year-on-year change?

Over the past year, LUCD TTM EBITDA has changed by +$10.65 M (+19.77%)